Abstract

The past decade has seen the identification of several mutations associated with low grade pediatric glioma—notably those to the v-raf murine sarcoma viral oncogene homolog B1 (BRAF). Further, next generation sequencing has recently led to the discovery of a wide variety of recurrent somatic mutations associated with low grade gliomas as well as elucidating the landscape of genetic alterations in low and high grade glioma. We have employed a novel methodology, postnatal electroporation coupled with piggyBac transposition in order to rapidly interrogate the causality of these mutations in tumorigenesis. Introduction of somatic mutation to tumor cells lining the ventricular zone led to a characteristic hyperplasia denoted by dramatic overgrowth of mutant cells. However, the cells rapidly senesced. In the minority of cases, tumors transition into invasive high grade glioblastoma. Co-introduction of additional tumor suppressor targeting elements (shRNA against p16/p19, Trp53 shRNA) increased tumor grade. Here, we discuss findings from our functional investigations of these putative low grade driver mutations.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.